19 October 2023
19 October 2023
The move aims to ease the burden on Canberra Hospital and North Canberra Hospital, where many patients are semi or non-urgent.
The combined entity will have 550 facilities and employ around 50,000 colleagues.
The funding aims to stabilise the physician presence in hospital emergency rooms.
The partnership will combine Avidex’s TigrPX patient engagement system with Artisight’s virtual care platform.
Ventricle Health's care model aims to reduce the average annual cost of heart failure care by 30-50%.
Wellcare members gain access to Galileo's personalised care, offered in various settings.
This collaboration aims to offer support to individuals waiting for behavioural health services.
The start-up uses a three-step plan to identify those who would most likely see clinical and financial value from treatment.
Join us on November 1st as Cynthia Bheling, Zobair Younossi, Rohit Loompa, and Vipul Jairath provide an overview of the drug development landscape.
With only a few approved drugs currently available to treat DN by means other than regulation of blood pressure, innovator products that can treat by targeting other factors such as treatment of dyslipidemia, hypertension, or angiotensin inhibition, among others, is a key area of R&D in the DN space and is likely to pave the way for novel therapies in the near future. However, the treatment landscape is expected to remain unchanged due to limited availability of products in the late-stage pipeline currently.
Give your business an edge with our leading industry insights.
